(Q40558398)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

21 September 2017

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

DNA methylation profiles of lymphoid and hematopoietic malignancies (English)

1 reference

21 September 2017

0 references

Sabine Zöchbauer-Müller

8

1 reference

21 September 2017

Takao Takahashi

1

1 reference

21 September 2017

Narayan Shivapurkar

2

1 reference

21 September 2017

Jyotsna Reddy

3

1 reference

21 September 2017

Hisayuki Shigematsu

4

1 reference

21 September 2017

Kuniharu Miyajima

5

1 reference

21 September 2017

Makoto Suzuki

6

1 reference

21 September 2017

Shinichi Toyooka

7

1 reference

21 September 2017

Johannes Drach

9

1 reference

21 September 2017

Gunjan Parikh

10

1 reference

21 September 2017

Yingye Zheng

11

1 reference

21 September 2017

Ziding Feng

12

1 reference

21 September 2017

Steven H Kroft

13

1 reference

21 September 2017

Charles Timmons

14

1 reference

21 September 2017

Robert W McKenna

15

1 reference

21 September 2017

Adi F Gazdar

16

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

21 September 2017

Clinical Cancer Research

1 reference

21 September 2017

10

1 reference

21 September 2017

2928-2935

1 reference

21 September 2017

9

1 reference

Retraction: DNA methylation profiles of lymphoid and hematopoietic malignancies

21 September 2017

0 references

cites work

Cancer statistics, 2003.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-03-0716

The Hallmarks of Cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-03-0716

p16(INK4a) and p15(INK4b) gene methylations in plasma cells from monoclonal gammopathy of undetermined significance

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-03-0716

Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-03-0716

Suppression of in vivo tumor growth and induction of suspension cell death by tissue inhibitor of metalloproteinases (TIMP)-3.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-03-0716

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-03-0716

Cadherin-13, a mediator of calcium-dependent cell-cell adhesion, is silenced by methylation in chronic myeloid leukemia and correlates with pretreatment risk profile and cytogenetic response to interferon alfa

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-03-0716

Alterations of the cyclin D1/pRb/p16(INK4A) pathway in multiple myeloma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-03-0716

A long-term study of prognosis in monoclonal gammopathy of undetermined significance.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-03-0716

Frequent inactivation of thep73gene by abnormal methylation or LOH in non-Hodgkin's lymphomas

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-03-0716

Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-03-0716

The epigenetics of colorectal cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-03-0716

Promoter Methylation and Silencing of the Retinoic Acid Receptor- Gene in Lung Carcinomas

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-03-0716

Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-03-0716

Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-03-0716

Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-03-0716

CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-03-0716

Aberrant promoter CpG methylation as a molecular marker for disease monitoring in natural killer cell lymphomas

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-03-0716

Different incidence and pattern of p15INK4b and p16INK4a promoter region hypermethylation in Hodgkin's and CD30-Positive non-Hodgkin's lymphomas

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-03-0716

Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-03-0716

Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-03-0716

DNA methylation and breast carcinogenesis.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-03-0716

Hypermethylation of a 5′ CpG island of p16 is a frequent event in non-Hodgkin’s lymphoma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-03-0716

Hypermethylation of p15/ink4b/MTS2 gene is differentially implicated among non-Hodgkin's lymphomas.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-03-0716

Aberrant gene promoter methylation in acute promyelocytic leukaemia: profile and prognostic significance

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-03-0716

The fundamental role of epigenetic events in cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-03-0716

Methylation profiling in acute myeloid leukemia.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-03-0716

Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-03-0716

Monoclonal gammopathy of undetermined significance (MGUS).

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-03-0716

The H-cadherin (CDH13) gene is inactivated in human lung cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/1078-0432.CCR-03-0716

Identifiers

DOI

10.1158/1078-0432.CCR-03-0716

1 reference

21 September 2017

1 reference